Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Project HOPES
NCT06029907Phase 4Completed
- Sponsor
- Duke University
- Start
- Jul 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of varenicline in Tobacco Use Disorder (TUD) and pain, sponsored by Duke University. Primary endpoints: Number of Participants Who Complete the Study at 9 months and Number of Participants Who Report That the Intervention Was Helpful at 9 months. Started Jul 2024; status: completed.
02
Drugs
varenicline
03
Conditions
Tobacco Use Disorder (TUD)pain
Beyond the preview
Go deeper on NCT06029907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06029907.